CFTC Commissioner Wetjen Resigns

Wetjen's resignation becomes effective August 28.

cftc-pic-6
Wetjen began serving as a CFTC commissioner in October 2011.

Wetjen was unanimously confirmed by the Senate in October 2011 and was acting chairman from January 2014 to June 2014. During his time with the CFTC, Wetjen helped to implement the Dodd-Frank Act, supported and helped craft 90 CFTC actions and oversaw the implementation of the first trading mandate for certain interest rate and credit default swaps.

At this time, Wetjen has no announced plans for where he will go.

"I am grateful for the opportunity to have served alongside my fellow commissioners and chairmen Gensler and Massad, and I thank them for their dedication, professionalism, and collegiality," said Wetjen in a statement. "I also commend the talented and hardworking Commission staff and am confident the Commission will continue to ensure the derivatives markets remain open, transparent, competitive, and financially sound."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here